US stock insider trading | Chemed disclosed one insider transaction on March 13

robot
Abstract generation in progress

On March 13, 2026, Chemed (CHE) disclosed an insider transaction. Director MCNAMARA KEVIN J sold 2,000 shares on March 12, 2026.

[Recent Insider Transactions]

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
March 13, 2026 Director MCNAMARA KEVIN J March 12, 2026 Sell 2,000 403.18 $806.4k
February 17, 2026 Executive Judkins Brian C February 13, 2026 Buy 249 469.56 $11,690
February 17, 2026 Director MCNAMARA KEVIN J February 13, 2026 Buy 1,522 469.56 $714.7k
February 17, 2026 Executive Witzeman Michael D February 13, 2026 Buy 293 469.56 $13,760
February 17, 2026 Executive Wherley Joel L February 13, 2026 Buy 193 469.56 $9,060
February 17, 2026 Executive LEE SPENCER S February 13, 2026 Buy 345 469.56 $16,200
February 17, 2026 Director HUTTON THOMAS C February 13, 2026 Buy 127 469.56 $5,960
November 25, 2025 Director MCNAMARA KEVIN J November 24, 2025 Sell 2,000 437.55 $875.1k
September 29, 2025 Director MCNAMARA KEVIN J September 26, 2025 Sell 3,000 461.28 $1.38M
September 10, 2025 Director GRACE PATRICK P September 9, 2025 Sell 150 463.39 $6,950

[Company Information]

Chemed Corporation was incorporated in Delaware in 1970. The company operates through two main business segments: VITAS, which provides hospice and palliative care services, and Roto-Rooter, which offers plumbing, sewer, and water restoration services.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin